Therapeutic perspective: starting an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in a diabetic patient

Target blood pressure attainment in diabetic hypertensive patients: need for more diuretics?

(2011) W.M. Sweileh   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

Advances in the treatment of prediabetes

(2010) Glenn Matfin et al.   Therapeutic Advances in Endocrinology and Metabolism

Left Ventricular Mass and Volume With Telmisartan, Ramipril, or Combination in Patients With Previous Atherosclerotic Events or With Diabetes Mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET])

(2009) Brett R. Cowan et al.   AMERICAN JOURNAL OF CARDIOLOGY

Role of Renin-Angiotensin System Blockade in Patients With Diabetes Mellitus

(2009) Manoela F.B. Braga et al.   AMERICAN JOURNAL OF CARDIOLOGY

Dipeptidyl Peptidase-IV Inhibitor Use Associated With Increased Risk of ACE Inhibitor-Associated Angioedema

(2009) Nancy J. Brown et al.   HYPERTENSION

ONTARGET, TRANSCEND, and PRoFESS: new-onset diabetes, atrial fibrillation, and left ventricular hypertrophy

(2009) Ulrich Kintscher   JOURNAL OF HYPERTENSION

Renal and Retinal Effects of Enalapril and Losartan in Type 1 Diabetes

(2009) Michael Mauer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial

(2008) Johannes FE Mann et al.   LANCET